Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 15 04:00PM ET
Dollar change
Percentage change
IndexS&P 500 P/E41.12 EPS (ttm)8.25 Insider Own6.23% Shs Outstand380.10M Perf Week-3.04%
Market Cap128.96B Forward P/E25.50 EPS next Y13.30 Insider Trans-1.55% Shs Float356.57M Perf Month-4.64%
Income3.17B PEG3.70 EPS next Q2.36 Inst Own81.44% Short Float1.19% Perf Quarter8.38%
Sales20.50B P/S6.29 EPS this Y11.97% Inst Trans1.53% Short Ratio3.36 Perf Half Y33.59%
Book/sh48.92 P/B6.93 EPS next Y12.06% ROA8.24% Short Interest4.24M Perf Year16.30%
Cash/sh8.03 P/C42.24 EPS next 5Y11.12% ROE17.98% 52W Range249.98 - 361.41 Perf YTD13.25%
Dividend Est.3.13 (0.92%) P/FCF41.12 EPS past 5Y-2.45% ROI10.60% 52W High-6.16% Beta0.92
Dividend TTM3.10 (0.91%) Quick Ratio0.97 Sales past 5Y8.80% Gross Margin60.89% 52W Low35.66% ATR (14)5.49
Dividend Ex-DateMar 27, 2024 Current Ratio1.58 EPS Y/Y TTM33.73% Oper. Margin21.16% RSI (14)35.60 Volatility1.61% 1.37%
Employees52000 Debt/Eq0.73 Sales Y/Y TTM11.11% Profit Margin15.44% Recom1.83 Target Price371.25
Option/ShortYes / Yes LT Debt/Eq0.61 EPS Q/Q102.17% Payout36.98% Rel Volume0.83 Prev Close342.05
Sales Surprise3.80% EPS Surprise5.85% Sales Q/Q11.78% EarningsApr 30 AMC Avg Volume1.26M Price339.13
SMA20-3.52% SMA50-3.19% SMA20011.80% Trades Volume1,048,440 Change-0.85%
Date Action Analyst Rating Change Price Target Change
Jan-31-24Upgrade Canaccord Genuity Hold → Buy $315 → $360
Oct-20-23Initiated ROTH MKM Buy $345
Sep-05-23Upgrade BofA Securities Neutral → Buy $310 → $315
Mar-29-23Initiated UBS Neutral $287
Jan-25-23Initiated KeyBanc Capital Markets Sector Weight
Jan-09-23Upgrade RBC Capital Mkts Sector Perform → Outperform $240 → $284
Nov-01-22Downgrade Canaccord Genuity Buy → Hold $225 → $220
Oct-18-22Initiated Barclays Overweight $239
Oct-12-22Initiated Jefferies Buy $270
Jul-28-22Upgrade Edward Jones Hold → Buy
Apr-05-24 04:42PM
Apr-01-24 04:05PM
Mar-29-24 09:40AM
Mar-27-24 10:54AM
Mar-26-24 04:05PM
08:02AM Loading…
Mar-22-24 10:39AM
Mar-21-24 11:39AM
Mar-19-24 02:23PM
Mar-07-24 04:23PM
Mar-06-24 08:46AM
Feb-29-24 10:31AM
12:04AM Loading…
Feb-28-24 02:10AM
Feb-22-24 05:25AM
Feb-18-24 01:26PM
Feb-15-24 12:07AM
Feb-13-24 02:41PM
Feb-07-24 08:00AM
Feb-05-24 08:00AM
Feb-01-24 03:03PM
Jan-31-24 07:29PM
10:35AM Loading…
Jan-30-24 11:06PM
Jan-29-24 08:22AM
Jan-25-24 10:50PM
Jan-24-24 11:25AM
Jan-22-24 05:16AM
Jan-18-24 08:50AM
Jan-17-24 08:00AM
Jan-15-24 10:03AM
Jan-12-24 03:49PM
Jan-10-24 08:35AM
Jan-08-24 07:20PM
Jan-05-24 08:00AM
Jan-04-24 07:09AM
Jan-02-24 12:10PM
Dec-27-23 05:03AM
Dec-20-23 06:06AM
Dec-19-23 05:00AM
Dec-18-23 09:00AM
Dec-07-23 08:00AM
Dec-06-23 08:00AM
Dec-05-23 08:00AM
Dec-04-23 07:27AM
Nov-26-23 05:56AM
Nov-20-23 06:52AM
Nov-15-23 07:00AM
Nov-09-23 12:09PM
Nov-04-23 01:21AM
Nov-03-23 06:30PM
Nov-02-23 06:20PM
Nov-01-23 08:42AM
Oct-31-23 07:37AM
Oct-30-23 04:05PM
Oct-26-23 10:02AM
Oct-25-23 05:59AM
Oct-24-23 04:57PM
Oct-17-23 11:32AM
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stiles Spencer SGroup PresidentMar 21 '24Option Exercise0.00203055,602Mar 25 07:21 PM
Pierce James AndrewGroup PresidentMar 21 '24Option Exercise0.00203060,664Mar 25 07:16 PM
Menon VijuGroup PresidentMar 21 '24Option Exercise0.00158013,762Mar 25 07:11 PM
Lobo KevinChair and CEOMar 21 '24Option Exercise0.009050119,719Mar 25 06:58 PM
Fletcher Robert SVP, Chief Legal OfficerMar 21 '24Option Exercise0.00120013,143Mar 25 06:54 PM
Fink M KathrynVP, Chief HR OfficerMar 21 '24Option Exercise0.0083013,710Mar 25 06:50 PM
Boehnlein Glenn SVP, Chief Financial OfficerMar 21 '24Option Exercise0.00256031,152Mar 25 06:45 PM
Becker Yin CVP, Chief Corp Affairs OfficerMar 21 '24Option Exercise0.0036029,898Mar 25 06:37 PM
Berry William E JrVP, Chief Accounting OfficerMar 08 '24Option Exercise154.141,480228,1275,155Mar 11 05:55 PM
Berry William E JrVP, Chief Accounting OfficerMar 07 '24Option Exercise108.3017,6601,912,58821,335Mar 11 05:55 PM
Berry William E JrVP, Chief Accounting OfficerMar 07 '24Sale358.487,6902,756,7303,675Mar 11 05:55 PM
Boehnlein Glenn SVP, Chief Financial OfficerFeb 09 '24Sale342.819,6003,290,95220,194Feb 12 04:09 PM
STRYKER RONDA EDirectorFeb 06 '24Sale339.9592,29631,376,0213,662,832Feb 07 05:33 PM
Becker Yin CVP, Chief Corp Affairs OfficerFeb 05 '24Option Exercise93.068,060750,06433,129Feb 07 05:00 PM
STRYKER RONDA EDirectorFeb 05 '24Sale342.90201,14668,973,3603,755,128Feb 07 05:33 PM
Golston Allan C.DirectorFeb 02 '24Option Exercise96.644,570441,64518,812Feb 06 05:24 PM
STRYKER RONDA EDirectorFeb 02 '24Option Exercise81.144,355353,3657,642Feb 06 05:16 PM
Golston Allan C.DirectorFeb 02 '24Sale341.003,2731,116,09314,242Feb 06 05:24 PM
Pierce James AndrewGroup PresidentJan 16 '24Option Exercise81.1410,230830,06257,999Jan 16 04:23 PM
Boehnlein Glenn SVP, Chief Financial OfficerJan 11 '24Option Exercise95.9960,0055,760,02268,981Jan 16 04:16 PM
Silvernail Andrew KDirectorDec 05 '23Option Exercise81.144,355353,36511,472Dec 07 04:57 PM
Datar Srikant M.DirectorDec 04 '23Option Exercise93.061,795167,0435,611Dec 05 04:25 PM
Datar Srikant M.DirectorDec 01 '23Sale298.22500149,1123,816Dec 05 04:25 PM
Becker Yin CVP, Chief Corp Affairs OfficerNov 28 '23Option Exercise81.148,875720,11830,806Nov 28 08:16 PM
Berry William E JrVP, Chief Accounting OfficerNov 28 '23Sale292.28573167,4772,909Nov 28 08:09 PM
Boehnlein Glenn SVP, Chief Financial OfficerNov 27 '23Option Exercise81.1411,955970,02916,570Nov 28 08:02 PM
Lobo KevinChair and CEONov 17 '23Option Exercise81.14160,21512,999,845241,249Nov 21 05:18 PM
Stiles Spencer SGroup PresidentNov 17 '23Option Exercise81.1411,090899,84353,732Nov 21 04:33 PM
Lobo KevinChair and CEONov 17 '23Sale287.9156,48316,261,81281,034Nov 21 05:18 PM
Datar Srikant M.DirectorNov 16 '23Sale291.92500145,9624,316Nov 16 05:56 PM
Datar Srikant M.DirectorNov 15 '23Sale287.50500143,7514,816Nov 16 05:56 PM
Datar Srikant M.DirectorNov 14 '23Sale287.57750215,6815,316Nov 16 05:56 PM
Menon VijuGroup PresidentSep 06 '23Sale289.005,0001,445,0006,994Sep 08 04:20 PM
Datar Srikant M.DirectorAug 10 '23Sale286.23750214,6716,066Aug 10 04:24 PM
Datar Srikant M.DirectorAug 08 '23Option Exercise93.062,000186,1207,467Aug 10 04:24 PM
Datar Srikant M.DirectorJun 01 '23Sale278.50500139,2505,467Jun 05 05:24 PM
Datar Srikant M.DirectorMay 18 '23Sale286.001,000286,0005,967May 19 06:29 PM
Skeete Tatum Lisa MDirectorMay 04 '23Option Exercise0.0084102,525May 08 04:40 PM
McCoy Sherilyn SDirectorMay 04 '23Option Exercise0.0084104,510May 08 04:34 PM
Suri RajeevDirectorMay 04 '23Option Exercise0.0084104,510May 08 04:45 PM
Caforio GiovanniDirectorMay 04 '23Option Exercise0.0084101,850May 08 04:29 PM
BRAINERD MARY KDirectorMay 04 '23Option Exercise0.0084105,110May 08 04:22 PM